Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy

<b>Background/Objectives</b>: Serum diagnostic tests for alopecia areata may be used to monitor response to treatment, aiding in the objective assessment of disease activity and helping to change treatment at an earlier point. Attenuated total reflection Fourier transform infrared (ATR-F...

Full description

Saved in:
Bibliographic Details
Main Authors: Charlotte Delrue, Arno Belpaire, Sigurd Delanghe, Matthijs Oyaert, Sander De Bruyne, Marijn M. Speeckaert, Reinhart Speeckaert
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/15/11/1369
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849330615368810496
author Charlotte Delrue
Arno Belpaire
Sigurd Delanghe
Matthijs Oyaert
Sander De Bruyne
Marijn M. Speeckaert
Reinhart Speeckaert
author_facet Charlotte Delrue
Arno Belpaire
Sigurd Delanghe
Matthijs Oyaert
Sander De Bruyne
Marijn M. Speeckaert
Reinhart Speeckaert
author_sort Charlotte Delrue
collection DOAJ
description <b>Background/Objectives</b>: Serum diagnostic tests for alopecia areata may be used to monitor response to treatment, aiding in the objective assessment of disease activity and helping to change treatment at an earlier point. Attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy offers a nondestructive and user-friendly approach for analyzing a wide range of samples. In this study, we evaluated whether ATR-FTIR spectroscopy combined with machine learning can detect alopecia areata and quantify disease activity. We also established whether patient-specific spectral differences correlate with response to therapy, offering molecular insight into treatment response. <b>Methods</b>: Serum samples from 42 patients with alopecia areata and 41 healthy donors were compared. Logistic regression models were developed to separate alopecia areata patients from controls and to monitor treatment response based on clinical scoring. <b>Results</b>: Significant spectral variations were found in the 3000–2800 cm<sup>−1</sup> and 1800–1000 cm<sup>−1</sup> regions corresponding to the principal biochemical constituents such as proteins, lipids, carbohydrates, and nucleic acids. The AUC of the logistic regression model for distinguishing alopecia areata patients from healthy controls was 0.85 (95% CI: 0.75–0.94) with a sensitivity of 0.89 and a specificity of 0.71. In terms of prediction of treatment response, the model showed discriminative potential (AUC = 0.86, 95% CI: 0.71–0.98), with distinct alterations in the spectrum, particularly in the Amide I band, associated with improvement in the patient’s condition. <b>Conclusions</b>: ATR-FTIR spectroscopy assisted by machine learning offers a serum-based solution for treatment monitoring in alopecia areata patients with clinical applicability. This technique has highly promising potential for the development of rapid, non-invasive, and objective biomarkers in autoimmune dermatology. Additional multi-center trials are required to validate and incorporate these spectral biomarkers into individual treatment regimens.
format Article
id doaj-art-e8d197ca03494e3b9c2b4570d164be4e
institution Kabale University
issn 2075-4418
language English
publishDate 2025-05-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-e8d197ca03494e3b9c2b4570d164be4e2025-08-20T03:46:50ZengMDPI AGDiagnostics2075-44182025-05-011511136910.3390/diagnostics15111369Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR SpectroscopyCharlotte Delrue0Arno Belpaire1Sigurd Delanghe2Matthijs Oyaert3Sander De Bruyne4Marijn M. Speeckaert5Reinhart Speeckaert6Department of Nephrology, Ghent University Hospital, 9000 Ghent, BelgiumDepartment of Dermatology, Ghent University Hospital, 9000 Ghent, BelgiumDepartment of Nephrology, Ghent University Hospital, 9000 Ghent, BelgiumDepartment of Laboratory Medicine, Ghent University Hospital, 9000 Ghent, BelgiumDepartment of Diagnostic Sciences, Ghent University, 9000 Ghent, BelgiumDepartment of Nephrology, Ghent University Hospital, 9000 Ghent, BelgiumDepartment of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium<b>Background/Objectives</b>: Serum diagnostic tests for alopecia areata may be used to monitor response to treatment, aiding in the objective assessment of disease activity and helping to change treatment at an earlier point. Attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy offers a nondestructive and user-friendly approach for analyzing a wide range of samples. In this study, we evaluated whether ATR-FTIR spectroscopy combined with machine learning can detect alopecia areata and quantify disease activity. We also established whether patient-specific spectral differences correlate with response to therapy, offering molecular insight into treatment response. <b>Methods</b>: Serum samples from 42 patients with alopecia areata and 41 healthy donors were compared. Logistic regression models were developed to separate alopecia areata patients from controls and to monitor treatment response based on clinical scoring. <b>Results</b>: Significant spectral variations were found in the 3000–2800 cm<sup>−1</sup> and 1800–1000 cm<sup>−1</sup> regions corresponding to the principal biochemical constituents such as proteins, lipids, carbohydrates, and nucleic acids. The AUC of the logistic regression model for distinguishing alopecia areata patients from healthy controls was 0.85 (95% CI: 0.75–0.94) with a sensitivity of 0.89 and a specificity of 0.71. In terms of prediction of treatment response, the model showed discriminative potential (AUC = 0.86, 95% CI: 0.71–0.98), with distinct alterations in the spectrum, particularly in the Amide I band, associated with improvement in the patient’s condition. <b>Conclusions</b>: ATR-FTIR spectroscopy assisted by machine learning offers a serum-based solution for treatment monitoring in alopecia areata patients with clinical applicability. This technique has highly promising potential for the development of rapid, non-invasive, and objective biomarkers in autoimmune dermatology. Additional multi-center trials are required to validate and incorporate these spectral biomarkers into individual treatment regimens.https://www.mdpi.com/2075-4418/15/11/1369alopecia areataATR-FTIR spectroscopymachine learning
spellingShingle Charlotte Delrue
Arno Belpaire
Sigurd Delanghe
Matthijs Oyaert
Sander De Bruyne
Marijn M. Speeckaert
Reinhart Speeckaert
Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy
Diagnostics
alopecia areata
ATR-FTIR spectroscopy
machine learning
title Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy
title_full Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy
title_fullStr Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy
title_full_unstemmed Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy
title_short Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy
title_sort serum based assessment of alopecia areata response to treatment using atr ftir spectroscopy
topic alopecia areata
ATR-FTIR spectroscopy
machine learning
url https://www.mdpi.com/2075-4418/15/11/1369
work_keys_str_mv AT charlottedelrue serumbasedassessmentofalopeciaareataresponsetotreatmentusingatrftirspectroscopy
AT arnobelpaire serumbasedassessmentofalopeciaareataresponsetotreatmentusingatrftirspectroscopy
AT sigurddelanghe serumbasedassessmentofalopeciaareataresponsetotreatmentusingatrftirspectroscopy
AT matthijsoyaert serumbasedassessmentofalopeciaareataresponsetotreatmentusingatrftirspectroscopy
AT sanderdebruyne serumbasedassessmentofalopeciaareataresponsetotreatmentusingatrftirspectroscopy
AT marijnmspeeckaert serumbasedassessmentofalopeciaareataresponsetotreatmentusingatrftirspectroscopy
AT reinhartspeeckaert serumbasedassessmentofalopeciaareataresponsetotreatmentusingatrftirspectroscopy